On Mar. 30, 2026, Biogen announced that the High Dose Regimen of SPINRAZA® (nusinersen), which is comprised of…
On Mar. 29, 2026, The South China Morning Post reported the cross-border outlicensing activities of Chinese biotech firms…
On Mar. 29, 2026, generative-AI drug developer Insilico Medicine announced that it has agreed to a global licensing…
On Mar. 27, 2026, a STAT survey conducted of nearly 1,000 National Institutes of Health (NIH) -supported scientists,…
On Mar. 27, 2026, Novartis announced an agreement to acquire Excellergy, a private biotech company developing next-generation anti-IgE…
On Mar. 27, 2026, A multi-institutional team of scientists, co-led by Northwestern University, has taken a crucial step…
On Mar. 23, 2026, The Walter and Eliza Hall Institute of Medical Research (WEHI) researchers have led a…
On Mar. 20, 2026, Novartis announced an agreement with Synnovation Therapeutics, to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor,…
On Mar. 19, 2026, The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo…
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
On Mar. 16, 2026, investigators from Mass General Brigham announce they have built metabolic polygenic risk scores (PRS) for predicting…
On Mar. 13, 2026, a research team lead by Boxuan Zhao, a professor of cell and developmental biology…
On Mar. 13, 2026, ImmunityBio announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a…
On Mar. 12, 2026, the Stanley Family Foundation renewed its commitment to psychiatric research at the Broad Institute,…
On Mar. 12, 2026, Mass General Brigham (MGB) announced it has received a $50 million gift that will…
On Mar. 11, 2026, taking a step towards developing genetic therapies at scale, researchers from Mass General Brigham…
On Mar. 10, 2026, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for…
On Mar. 8, 2026, a new statewide spatial analysis of Alzheimer’s disease and related dementias (ADRD) has uncovered…
On Mar. 6, 2026, Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved…
On Mar. 6, 2026, Sumitomo Pharma announce it has obtained conditional and time‑limited approval in Japan for the…
On Mar. 6, 2026, researchers at Baylor College of Medicine announced they have discovered a potential new strategy…
On Mar. 5, 2026, China has approved Pfizer’s GLP-1 treatment Xianweiying for long-term weight management in overweight or…
On Feb. 26, 2026, A University of California Davis Health research team has safely performed the world’s first spina…
On Feb. 26, 2026, Novartis announced it has settled a lawsuit by the estate of Henrietta Lacks that…
On Feb. 23, 2026, Gilead Sciences announced it will buy cancer therapy partner Arcellx for an implied equity…
On Feb. 19, 2026, Phil and Penny Knight announced they have given a second transformational gift of $75 million…
On Feb. 18, 2026, researchers at SANKEN, University of Osaka announced using a nanoreactor to produce pores that…
On Feb. 18, 2026, Johnson & Johnson announced announced a more than $1 billion investment in a next…
On Feb. 17, 2026, Fred Hutch Cancer Center scientists announced reaching a crucial milestone in blocking Epstein Barr…